À propos de l'héminégligence: bilan et perspectives

Paillard, Jean-Francois; Badan, Maryse

doi:10.1016/s0168-6054(97)84827-1

Cited by 5 publications

(1 citation statement)

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The following parameters will be determined: gender, age, the presence of any previous or current cerebral pathology, cerebral trauma or cancer, initial neurological symptoms, complete physical examination, initial tumour location, its grade, period in time since surgery, type of surgery (biopsy, partial resection and full resection), Karnofsky Performance Score, type of adjuvant treatment (radiotherapy, type of chemotherapy) and radiological response to adjuvant treatment according to the Response Assessment in Neuro-Oncology (RANO assessment). 38 The hemineglect will be evaluated by the line section task 39 while their cognitive status will be investigated by the Montreal Cognitive Assessment test, 40 the complex Rey figure, 41 the trail making test 42 and Raven’s coloured progressive matrices. 43…”

Section: Methodsmentioning

confidence: 99%

Caregivers’ quality of life and psychological health in response to functional, cognitive, neuropsychiatric and social deficits of patients with brain tumour: protocol for a cross-sectional study

et al. 2017

View full text Add to dashboard Cite

IntroductionPatients with gliomas generally present cognitive, neuropsychiatric and functional deficits. Although previous research has shown that their caregivers present a poor quality of life and poor mental health, only a few studies have tested in a comprehensive way which deficits/preserved abilities of patients predominantly impact their caregivers. Furthermore, only a few studies have focused on the social impact of gliomas, which may also damage the caregivers’ quality of life. Therefore, this cross-sectional study aims to investigate which patients’ impairments are particularly deleterious for the caregivers and whether the histological characteristics of the gliomas also affect their quality of life.Methods and analysisIn order to examine these research questions, this study intends to include 180 patients (60 patients with grade II gliomas, 60 patients with grade III gliomas and 60 patients with grade IV gliomas), their caregivers and 60 healthy controls. While patients will complete a full battery of cognitive, neuropsychiatric, functional and social tests, caregivers will complete questionnaires about their quality of life, depression, anxiety and burden. Patients’ performances and caregivers’ reports of depression and anxiety will be compared with the scores of healthy controls. Eventually, our aim will be to provide specific care support both to reduce patients’ deficits and alleviate caregivers’ difficulties.Ethics and disseminationThe study has obtained the approval of the local faculty ethics committee (‘Comité d’éthique en sciences comportementales’; 2016–5 S41 and 2015–3 S37). On completion of the study, data will be kept by Lille University for 5 years before they are destroyed. Study findings will be disseminated through peer-reviewed journal publications and conference presentations with no reference to a specific individual.

show abstract